Hypermethylation of a 5′ CpG island of p16 gene has been
Introduction
PCR was used to determine the methylation status of the first exon of p16, as described by other authors. 23 ,24 Genomic Homozygous and hemizygous deletions on chromosome DNA (5 g) was initially digested using the methylation sensi9p21 have been frequently reported in a wide variety of tumor tive enzyme, EagI. It has one restriction site inside exon 1. cell lines including hematological malignancies, suggesting EagI cuts this site when it is not methylated. Digestion was the presence of one or more tumor suppressor genes in this performed with 40 units of the enzyme, overnight. Digested region. One gene possibly involved in this region is DNA (100 ng) was then amplified in a multiple PCR reaction p16/CDKN2. 1 This gene encodes an inhibitor of cyclinwith exon 2 of the p16 gene; exon 2 was used as an internal dependent kinase 4 (CDK4). When P16 protein binds to control since exon 2 does not have an EagI restriction site. CDK4, progression through the G1 phase of the cell cycle is Primers used for the amplification of p16 exon 1 and 2 were prevented. [2] [3] [4] Deletions or mutations in this gene result in an previously described. 4 PCR conditions were as follows: 94°C abnormal cell growth. Mutations of p16 occur frequently in for 5 min, 5 cycles of 94°C for 30 s, 68°C for 30 s and 72°C melanoma 5, 6 and pancreatic carcinomas 7 but are rare in for 1 min, followed by 25 cycles of 94°C for 30 s, 60°C for numerous primary tumors. 30 s and 72°C for 1 min, using a BIOMETRA PCR system In hematological malignancies, homozygous deletions or (Gö ttingen, Germany). PCR products were resolved on a 3% loss of heterozygosity (LOH) have been demonstrated mainly Methaphor agarose (FMC Bioproducts, Rockland, ME, USA) in acute lymphoblastic leukemias. [8] [9] [10] [11] [12] Deletions, as well as gel. After digestion only tumors with hypermethylated p16 mutations in this gene, are infrequent in non-Hodgkin's lymexperienced amplification of exon 1, while in non-methylated phoma (NHL).
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tumors it was not possible to PCR amplify this exon. Exon 2 Recently, de novo methylation of a 5′ CpG island of p16 of p16 amplified in all tumors. In every amplification we has been reported. This methylation involves loss of transcripincluded an undigested DNA control. Also we used reactive tion in most cell lines and primary tumors analyzed, 18-21 and tonsils to test if normal lymphoid tissue were methylated in could represent an alternative mechanism of inactivation of this region. the gene.
We have analyzed the methylation status of p16 gene in a large group of lymphomas previously studied, in which we Southern hybridization did not find homozygous deletions and only one case had a mutation in the gene. 22 The aim of this work is to prove that Tumors were also subjected to Southern blot analysis to conhypermethylation can be another alternative way of inactifirm the methylation status of the p16 exon 1 CpG island, vation of p16 gene in lymphomas.
using overnight using 40 units of EcoRI and 60 units of SacII enzyme, electrophoresed in a 0.8% agarose gel, and then transferred to a Zeta-Probe GT nylon membrane (Bio-Rad, Hercules, CA, USA). Filters were then hybridized with a PCRgenerated probe corresponding to exon 1 of p16 which was amplified with the same primers used for PCR-based analysis. After overnight hybridization, filters were subjected to stringent washes and exposed to X-ray film for 2-5 days.
Results
Methylation status of two sites in exon 1 of p16 was analyzed by PCR and Southern blotting using two methylation-sensitive enzymes: EagI and SacII (Figures 2 and 3 ). We examined a group of primary lymphomas of different histologic subtypes, mainly of B cell origin (62 cases) and a smaller group of 20 T cell lymphomas; also five reactive tonsils from normal patients were studied for methylation of the p16 gene.
As shown in Figure 2 , exon 1 of p16 amplified after digestion with EagI only in cases with p16 methylation. In contrast, all cases amplified exon 2 which lacks an EagI site. These methylated cases showed different intensity in bands corresponding to exon 1 ( Figure 2 ). These differences in the intensity of methylated bands may result from a partial rather than increased to 44% (4/9) of low-grade MALT lymphomas and Thus we found 20 tumors methylated at the SacII site. In two high-grade MALT lymphomas only the 4.3 kb fragment was observed, indicating that these tumors are completely methylated. In eight cases both the 3.3 kb and the 3.6 kb fragments were observed, and the other 10 cases showed the 4.3 kb and the 3.3 kb fragments. In all normal lymphoid tissue only the 3.3 kb band was detected. The presence of the 3.3 kb band in methylated lymphomas could be due to normal cells accompanying the tumor or perhaps methylation affected only one of the alleles of the p16 gene.
Discussion

Figure 3
Methylation analysis at 5′CpG island of p16 by Southern blot. Cases were digested using EcoRI and SacII enzymes and hybridized with an exon 1 probe. Size of the fragments, in kb, are
The p16 gene encodes an inhibitor of cyclin-dependent kin- were very rare. 22 Based on these preliminary results we analyzed a higher number of lymphomas to know if methylation of the 5′ CpG island at p16 exon 1 could be an alternative 100% (6/6) of high-grade MALT lymphomas (Table 1 ). In T cell NHL we have found hypermethylation in 3/20 (15%) lymmechanism of inactivation of p16 gene in NHL as have been described overall in other tumor types. [18] [19] [20] phomas analyzed, these being three cases of high-grade lymphomas.
In the present work, in 21% of B cell NHL, both low (25%) and high grade (19%), and 15% of T cell NHL, exon 1 of the Methylation at the SacII site was analyzed by Southern blot. Methylation at SacII site was confirmed in 20/23 cases methylp16 gene was hypermethylated ( Figure  3 ), while methylated cases showed a 4.3 kb fragment, as Although in all these tumors hypermethylation at exon 1 was correlated with loss or decreased expression of the gene, a occurred when digestion was only with EcoRI. However, if only the SacII site localized inside p16 exon 1 was methylreduced level of p16 in unmethylated cases has been described in acute myeloid leukemias. 25 Interestingly, in our ated, we obtained a 3.6 kb fragment (Figure 3) . bility remains to be proved in further studies.
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